Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
NCT05894512 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2026-03-03
Summary
The aim of this observational study is to provide analysis of T and B lymphocyte subgroups in peripheral blood samples of patients with primary membranous nephropathy (MN). A search for disease-related circulating antibodies \[anti-phospholipase A2 receptor antibody (anti-PLA2R) and anti-thrombospondin type 1 domain-containing 7A antibody (anti-THSD7A)\] in patients' sera is also planned.
The main questions to answer are:
1. What is the relationship of these cell populations and their distribution during follow-up with treatment, treatment responses, and relapses?
2. What is the relationship of the cell populations with anti-PLA2R (or anti-THSD7A) antibody levels?
Participants will provide peripheral venous blood samples at pre-designated regular intervals.
The research team will compare results of the primary MN group with two control groups (IgA nephropathy and healthy volunteer groups) to see if the findings are specific for primary MN.
Conditions
- Membranous Nephropathy
- Membranous Nephropathy - PLA2R Induced
- Membranous Nephropathy - THSD7A Induced
Sponsors & Collaborators
-
Istanbul University
lead OTHER
Principal Investigators
-
Suzan Adin Cinar, PhD · Istanbul University
-
Safak Mirioglu, MD · Istanbul University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2026-02-15
- Completion
- 2026-02-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
NCT00987389 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
NCT05755386 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease
NCT03635385 ·Status: COMPLETED ·Phase: NA
-
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Prospective & Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases
NCT04509570 ·Status: COMPLETED ·Phase: NA
-
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
NCT00315497 ·Status: COMPLETED
-
Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
NCT01539902 ·Status: UNKNOWN ·Phase: PHASE2
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4
-
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840 ·Status: COMPLETED
-
Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome
NCT03501459 ·Status: RECRUITING ·Phase: PHASE3
-
Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant
NCT00188825 ·Status: COMPLETED ·Phase: PHASE3
-
INS, B Cells and Microbiota
NCT04924712 ·Status: RECRUITING
-
The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis
NCT03531996 ·Status: COMPLETED
-
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
NCT07160608 ·Status: RECRUITING ·Phase: PHASE2
-
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
NCT00001350 ·Status: RECRUITING
-
Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
NCT01559155 ·Status: TERMINATED
-
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT00685373 ·Status: COMPLETED ·Phase: PHASE3
-
The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis
NCT02627209 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
NCT02592798 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
NCT01610492 ·Status: COMPLETED ·Phase: PHASE2
-
Thrombophilia and Thrombosis in Behçet's Disease
NCT06451575 ·Status: RECRUITING
-
Autoreactive B Cells in Membranous Nephropathy
NCT04095156 ·Status: RECRUITING
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2